¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"hyperplastic chondrodystrophy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chondrodystrophy
    ¿¬°ñ¹ß»ýÀå¾Ö
  • hyperplastic
    °ú´ÙÇü¼º-, Áõ½Ä-
  • hyperplastic arteriolosclerosis
    Áõ½Ä¼¼µ¿¸Æ°æÈ­(Áõ)
  • hyperplastic diaphyseal periosteitis
    Áõ½Ä»À¸öÅë»À¸·¿°, Áõ½Ä°ñ°£°ñ¸·¿°
  • hyperplastic epidermolysis bullosa
    Áõ½Ä¹°ÁýÇ¥Çǹڸ®Áõ
  • hyperplastic polyp
    Áõ½ÄÆú¸³
  • hyperplastic rhinitis
    Áõ½ÄÄÚ¿°, Áõ½Äºñ¿°
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chondrodystrophy
    ¿¬°ñ¹ß»ýÀå¾Ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chondrodystrophy
    ¿¬°ñ¹ß»ýÀå¾Ö
  • hyperplastic arteriolosclerosis
    Áõ½Ä¼¼µ¿¸Æ°æÈ­Áõ
  • hyperplastic candidiasis
    Áõ½ÄÄ­µð´ÙÁõ
  • hyperplastic epidermolysis bullosa
    Áõ½Ä¹°ÁýÇ¥Çǹڸ®Áõ
  • hyperplastic
    °ú´ÙÇü¼º-, Áõ½Ä-
  • hyperplastic rhinitis
    Áõ½ÄÄÚ¿°, Áõ½Äºñ¿°
  • hyperplastic sinusitis
    Áõ½ÄÄÚ°ç±¼¿°, Áõ½ÄºÎºñµ¿¿°
  • hyperplastic diaphyseal periosteitis
    Áõ½Ä»À¸öÅë»À¸·¿°, Áõ½Ä°ñ°£°ñ¸·¿°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hyperplastic
    °úÇü¼º¼º(Φû¡à÷àõ), Áõ½Ä¼º(ñòãÖàõ)ÀÇ.
  • hyperplastic candidiasis
    Áõ½Ä¼ºÄ­µð´ÙÁõ
  • hyperplastic diaphyseal periosteitis
    Áõ½Ä¼º °ñ°£ °ñ¸·¿°.
  • hyperplastic epidermolysis bullosa
    °úÇü¼º ¼öÆ÷¼º Ç¥Çǹڸ®Áõ
  • hyperplastic graft
    Áõ½Ä¼º ÀÌ½ÄÆí(Áõ½Ä¼ºÀÌ½ÄÆí).
  • hyperplastic graft
    Áõ½Ä¼º ÀÌ½ÄÆí(ñòãÖàõì¹ãÖø¸).
  • hyperplastic rhinitis =r. hyperplastica <³ª>
    Áõ½Ä(¼º) ºñ¿°
  • hyperplastic sinusitis
    Áõ½Ä(¼º) ºÎºñµ¿¿°
  • persistent hyperplastic vitreous
    ÀÏÂ÷À¯¸®Ã¼Áõ½ÄÁõ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chondrodystrophy
    ¿¬°ñ ÀÌ¿µ¾çÁõ (æãÍéì¶ç½å×ñø).
  • arteriolosclerosis,hyperplastic
    Áõ½Ä¼º(ñòãÖàõ)
  • focus, hyperplastic
    ¼¼Æ÷°úÁõ½Ä Æ÷Ä¿½º
  • hyperplastic
    °úÇü¼º¼º(Φû¡à÷àõ), Áõ½Ä¼º(ñòãÖàõ)ÀÇ.
  • hyperplastic candidiasis
    Áõ½Ä¼ºÄ­µð´ÙÁõ
  • hyperplastic diaphyseal periosteitis
    Áõ½Ä¼º °ñ°£ °ñ¸·¿°.
  • hyperplastic epidermolysis bullosa
    °úÇü¼º ¼öÆ÷¼º Ç¥Çǹڸ®Áõ
  • hyperplastic graft
    Áõ½Ä¼º ÀÌ½ÄÆí(Áõ½Ä¼ºÀÌ½ÄÆí).
  • hyperplastic graft
    Áõ½Ä¼º ÀÌ½ÄÆí(ñòãÖàõì¹ãÖø¸).
  • hyperplastic rhinitis =r. hyperplastica <³ª>
    Áõ½Ä(¼º) ºñ¿°
  • hyperplastic sinusitis
    Áõ½Ä(¼º) ºÎºñµ¿¿°
  • persistent hyperplastic primary vitreous
  • persistent hyperplastic vitreous
    ÀÏÂ÷À¯¸®Ã¼Áõ½ÄÁõ
  • rhinitis, hyperplastic [=r. hyperplastica <³ª>]
    Áõ½Ä(¼º) ºñ¿°
  • secondary hyperplastic osteitis
    ÀÌÂ÷¼º Áõ½Ä¼º °ñ¿°(ì£ó­àõñòãÖàõÍéæú).
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hyperplastic
    °úÇü¼º¼º, Áõ½Ä¼ºÀÇ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
HAN heroin-associated nephropathy; hyperplastic alveolar nodule
HLN hilar lymph node; hyperplastic liver nodules
PHPV persistent hyperplastic primary vitreous
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
HP Hyperplastic Polyps
HAN Hyperplastic alveolar nodules
HN Hyperplastic nodules
PHPV Persistent Hyperplastic Primary Vitreous
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • chronic hyperplastic gingivitis
    ¸¸¼º Áõ½Ä¼º Ä¡Àº¿°
  • hyperplastic
    °úÇü¼º¼º, Áõ½Ä¼º
    Á¶Á÷ÀÇ Á¤»ó ±¸Á¶ ³»¿¡¼­ Á¤»ó ¼¼Æ÷ÀÇ ±¸Á¶°¡ ºñÁ¤»óÀûÀ¸·Î Áõ°¡ÇÏ´Â »óÅÂÀÇ.
  • hyperplastic change
    Áõ½Ä¼º º¯È­
  • hyperplastic graft
    Áõ½Ä¼º À̽Ä
    ¿°ÁõÀ¸·ÎºÎÅÍ È¸º¹ÇÏ´Â »óÅÂ¿Í °°Àº Ȱµ¿Àû º¹¿ø »óÅ¿¡¼­ÀÇ ÇǺΠÀ̽Ä.
  • hyperplastic rhinitis
    Áõ½Ä¼º ºñ¿°
  • hyperplastic tissue
    °úÇü¼º Á¶Á÷
  • noninflammatory hyperplastic gingival enlargement
    ºñ¿°Áõ¼º Áõ½Ä¼º Ä¡Àº ºñ´ë
  • shaggy hyperplastic change
    ²¬²ô·¯¿î °úÁõ½Ä º¯È­
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
asphyxiating thoracic chondrodystrophy Hereditary hypoplasia of the thorax, associated with pelvic skeletal abnormality.
Synonym: asphyxiating thoracic chondrodystrophy, Jeune's syndrome, thoracic-pelvic-phalangeal dystrophy.
(05 Mar 2000)
asymmetrical chondrodystrophy Benign growths of cartilage in the metaphyses of several bones.
(12 Dec 1998)
chondrodystrophy A disturbance in the development of cartilage, primarily the long bones. This can result in arrested growth and dwarfism.
(27 Sep 1997)
hereditary deforming chondrodystrophy A disturbance of enchondral bone growth in which multiple, generally benign osteochondromas of long bones appear during childhood, commonly with shortening of the radius and fibula; the ill-effects are usually mechanical but malignant change is rare; autosomal dominant inheritance.
Synonym: diaphysial aclasis, hereditary deforming chondrodystrophy, multiple exostosis, osteochondromatosis.
(05 Mar 2000)
hypoplastic foetal chondrodystrophy A developmental error of the epiphyses characterised by severe deformities, epiphyses ossified from several discrete centres and with a stippled appearance, and thickened shafts of the long bones; congenital cataract and mental retardation are often present. There is an autosomal dominant form and an autosomal recessive form.
Synonym: chondrodysplasia punctata, chondrodystrophia calcificans congenita, hypoplastic foetal chondrodystrophy, stippled epiphysis.
(05 Mar 2000)
persistent anterior hyperplastic primary vitreous A unilateral congenital abnormality occurring in full-term infants; characterised by a retrolental fibrovascular membrane formed by persistent primary vitreous with remnants of the hyaloid artery and tunica vasculosa lentis; associated with leukokoria, microphthalmos, shallow anterior chamber, and elongated ciliary processes.
(05 Mar 2000)
persistent posterior hyperplastic primary vitreous A unilateral congenital anomaly in full-term infants; associated with a congenital retinal fold and a vitreous membranous stalk containing remnants of the hyaloid artery.
(05 Mar 2000)
hyperplastic 1. Of or pertaining to hyperplasia.
2. <biology> Tending to excess of formative action.
Source: Websters Dictionary
(01 Mar 1998)
hyperplastic arteriosclerosis Hyperplasia of the intima and internal elastic layer and hypertrophy of the media independent of atheromatous lesions.
(05 Mar 2000)
hyperplastic cholecystosis <radiology> Variety of degenerative and proliferative changes of gallbladder, wall characterised by hyperconcentration, hyperexcitability, and hyperexcretion, incidence: 30-50% of cholecystectomy specimens, M:F = 1:6 types: cholesterolosis, adenomyomatosis of gallbladder see: focal gallbladder wall thickening
(12 Dec 1998)
hyperplastic gastric polyp <radiology> Regeneration polyp, inflammatory polyp, most common type of gastric polyp (75-90%), histology: proliferated gastric mucosa with acute and chronic inflammatory infiltrates in lamina propria, location: randomly distributed in stomach, associated with, chronic atrophic gastritis, pernicious anaemia, findings: sharply delineated polyp with smooth circular border, Mexican hat sign: stalk seen en face overlying the head of the polyp, sessile/pedunculate; usually multiple, usually less than 1 cm, no contour defect in stomach
(12 Dec 1998)
hyperplastic gingivitis Gingivitis of long-standing duration in which the gingiva becomes enlarged and firm due to proliferation of fibrous connective tissue.
(05 Mar 2000)
hyperplastic graft A graft in active proliferation.
(05 Mar 2000)
hyperplastic inflammation An inflammatory reaction in which the distinguishing feature is an actual increase in the number of tissue cells, especially the reticuloendothelial macrophages, in contrast to cells exuded from blood vessels; in addition, exudates of various types are likely to be observed in granulomas and other forms of proliferative inflammation, but the latter may occur without an exudate being formed (as in certain infections caused by virus).
Synonym: hyperplastic inflammation.
(05 Mar 2000)
hyperplastic osteoarthritis hypertrophic pulmonary osteoarthropathy
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á